ALKUM COUGH EXPECTORANT

This brand name is authorized in Nigeria.

Active ingredients

The drug ALKUM COUGH EXPECTORANT contains a combination of these active pharmaceutical ingredients (APIs):

1	Cetirizine UNII 64O047KTOA - CETIRIZINE HYDROCHLORIDE
	Cetirizine, a human metabolite of hydroxyzine, is a potent and selective antagonist of peripheral H1-receptors. In vitro receptor binding studies have shown no measurable affinity for other than Η1-receptors.
	Read more about Cetirizine
2	Ammonium chloride UNII 01Q9PC255D - AMMONIUM CHLORIDE
	Read more about Ammonium chloride
3	Menthol UNII L7T10EIP3A - MENTHOL, UNSPECIFIED FORM
	Read more about Menthol
4	Sodium citrate UNII 1Q73Q2JULR - SODIUM CITRATE, UNSPECIFIED FORM
	Sodium citrate has no relevant pharmacodynamic activity other than that caused by its alkalinity (e.g. its gastric acid neutralising capacity). Sodium citrate is a non-particulate antacid for use by mouth to prior to general anaesthesia for caesarean section.
	Read more about Sodium citrate

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
R05CA10	Combinations	R Respiratory system → R05 Cough and cold preparations → R05C Expectorants, excl. combinations with cough suppressants → R05CA Expectorants
Discover more medicines within R05CA10

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-4057
Switch country to Nigeria in order to find specific presentations of ALKUM COUGH EXPECTORANT